Nanobiotix S.A. Increase Decrease In Cash And Cash Equivalents
Nanobiotix S.A. (NNBXF) reported Increase Decrease In Cash And Cash Equivalents of EUR 3.01 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2026-03-31
| Period end | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|
| 2025-12-31 | 3.01M EUR 20-F · filed 2026-03-31 | |
| 2025-06-30 | -20.92M EUR 6-K · filed 2025-09-30 | |
| 2024-12-31 | -25.55M EUR 20-F · filed 2026-03-31 | |
| 2024-06-30 | -8.95M EUR 6-K · filed 2025-09-30 | |
| 2023-12-31 | 33.90M EUR 20-F · filed 2026-03-31 | |
| 2023-06-30 | -19.76M EUR 6-K · filed 2024-09-18 | |
| 2022-12-31 | -42.53M EUR 20-F · filed 2025-04-02 | |
| 2022-06-30 | -20.90M EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | -35.23M EUR 20-F · filed 2024-04-24 | |
| 2021-06-30 | -16.81M EUR 6-K · filed 2022-09-28 | |
| 2020-12-31 | 84.06M EUR 20-F · filed 2023-04-24 | |
| 2020-06-30 | -8.51M EUR 6-K · filed 2021-09-08 | |
| 2019-12-31 | -1.11M EUR 20-F · filed 2022-04-08 | |
| 2018-12-31 | -11.01M EUR 20-F/A · filed 2021-04-08 |